Carregant...
PROTACs: great opportunities for academia and industry
Although many kinds of therapies are applied in the clinic, drug-resistance is a major and unavoidable problem. Another disturbing statistic is the limited number of drug targets, which are presently only 20–25% of all protein targets that are currently being studied. Moreover, the focus of current...
Guardat en:
| Publicat a: | Signal Transduct Target Ther |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927964/ https://ncbi.nlm.nih.gov/pubmed/31885879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-019-0101-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|